Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-138427
Filing Date
2024-12-19
Accepted
2024-12-19 16:05:03
Documents
2
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1607
2 EX-24 beam-ex24.htm EX-24 13646
  Complete submission text file 0000950170-24-138427.txt   16666
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Issuer) CIK: 0001745999 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 SUMMER ST SUITE 2300 BOSTON MA 02109
Business Address
Emany Sravan Kumar (Reporting) CIK: 0001897662 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39208 | Film No.: 241563299